|
Name |
7-Methyl-1,3-dihydro-2-benzofuran-4,5,6-triol
|
Molecular Formula | C9H10O4 | |
IUPAC Name* |
7-methyl-1,3-dihydro-2-benzofuran-4,5,6-triol
|
|
SMILES |
CC1=C2COCC2=C(C(=C1O)O)O
|
|
InChI |
InChI=1S/C9H10O4/c1-4-5-2-13-3-6(5)8(11)9(12)7(4)10/h10-12H,2-3H2,1H3
|
|
InChIKey |
VPYMCXHMAIDUNK-UHFFFAOYSA-N
|
|
Synonyms |
7-methyl-1,3-dihydro-2-benzofuran-4,5,6-triol; 185018-44-4; 7-methyl-1,3-dihydroisobenzofuran-4,5,6-triol; NC-3B; 4,5,6-Isobenzofurantriol, 1,3-dihydro-7-methyl-; CHEMBL4170170; DTXSID10445665; ZINC90375675; AKOS006327724; EN300-269985; 4,5,6-trihydroxy-7-methyl-1,3-dihydroisobenzofuran
|
|
CAS | 185018-44-4 | |
PubChem CID | 10845133 | |
ChEMBL ID | CHEMBL4170170 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 182.17 | ALogp: | 0.4 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 69.9 | Aromatic Rings: | 2 |
Heavy Atoms: | 13 | QED Weighted: | 0.533 |
Caco-2 Permeability: | -4.947 | MDCK Permeability: | 0.00000781 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.01 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.964 |
30% Bioavailability (F30%): | 0.978 |
Blood-Brain-Barrier Penetration (BBB): | 0.062 | Plasma Protein Binding (PPB): | 86.21% |
Volume Distribution (VD): | 0.354 | Fu: | 8.26% |
CYP1A2-inhibitor: | 0.117 | CYP1A2-substrate: | 0.707 |
CYP2C19-inhibitor: | 0.018 | CYP2C19-substrate: | 0.108 |
CYP2C9-inhibitor: | 0.026 | CYP2C9-substrate: | 0.104 |
CYP2D6-inhibitor: | 0.027 | CYP2D6-substrate: | 0.19 |
CYP3A4-inhibitor: | 0.017 | CYP3A4-substrate: | 0.089 |
Clearance (CL): | 6.353 | Half-life (T1/2): | 0.96 |
hERG Blockers: | 0.078 | Human Hepatotoxicity (H-HT): | 0.282 |
Drug-inuced Liver Injury (DILI): | 0.11 | AMES Toxicity: | 0.703 |
Rat Oral Acute Toxicity: | 0.122 | Maximum Recommended Daily Dose: | 0.035 |
Skin Sensitization: | 0.945 | Carcinogencity: | 0.339 |
Eye Corrosion: | 0.005 | Eye Irritation: | 0.914 |
Respiratory Toxicity: | 0.086 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005415 | 1.000 | D0R6BI | 0.205 | ||||
ENC003333 | 0.659 | D09EBS | 0.194 | ||||
ENC004505 | 0.659 | D07MUN | 0.193 | ||||
ENC004923 | 0.569 | D07MGA | 0.185 | ||||
ENC004506 | 0.532 | D0YH0N | 0.182 | ||||
ENC003016 | 0.532 | D07EXH | 0.180 | ||||
ENC004984 | 0.532 | D0H6QU | 0.179 | ||||
ENC004922 | 0.492 | D04FBR | 0.173 | ||||
ENC004924 | 0.396 | D0K8KX | 0.173 | ||||
ENC001496 | 0.392 | D0Y8ZN | 0.171 |